This cross-sectional study examines changes in the prescribing of oral targeted therapy alongside the frequency of comanagement of advanced prostate cancer between urologists and medical oncologists.
No takes yet. Share an insight, caveat, or question.
Srivastava et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: